Medication info
Hyco Tablet 20mg (Simvastatin)

Hyco Tablet 20mg (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
HUBIST Pharmaceutical Co., Ltd.
Appearance
Brownish-yellow oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201405436 · Approved 2014.11.21 · Insurance code 628800460

Summary

Main use
Treatment of hyperlipidemia and heterozygous familial hypercholesterolemia in children; prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Before and during treatment with this drug, patients must follow a standard cholesterol-lowering diet. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. A dose of 5 ~ 40 mg of this drug once daily in the evening is recommended. Before starting treatment, adjust the dose as appropriate according to the baseline LDL cholesterol level, treatment goal, and patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if cholesterol levels fall below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of this drug at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this drug for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) For recommended doses in patients receiving this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), refer to the information below (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should receive 40 mg of this drug once daily in the evening. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this drug. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this drug is coadministered with verapamil, diltiazem, or dronedarone, the dose of this drug should not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this drug is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this drug should not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering drugs This drug is effective when used alone or in combination with bile acid sequestrants. When this drug is coadministered with fibrates (excluding gemfibrozil (see 2. Patients in whom the drug is contraindicated under Precautions for Use) and fenofibrate), the dose of this drug should not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this drug is not extensively excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg per day and monitor carefully.
Child dose
3. Administration to pediatric patients (10 ~ 17 years) with heterozygous familial hypercholesterolemia The recommended initial dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or more between dose adjustments.

Ingredients

Manufacturer
HUBIST Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hyperlipidemia and heterozygous familial hypercholesterolemia in children; prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hypercholesterolemia
  • dyslipidemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular disease. It particularly lowers the risk of heart attacks or strokes in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, and stroke, also reducing coronary mortality rates. Additionally, it is effective in treating hyperlipidemia, reducing cholesterol and triglycerides in various types of hypercholesterolemia and mixed dyslipidemia patients, while increasing good cholesterol (HDL). It is also used in conjunction with diet for pediatric patients with heterozygous familial hypercholesterolemia who have a family history. Overall, this medication improves cardiovascular health and decreases the risk of vascular-related diseases.

How to take

Adult dose

Before and during treatment with this drug, patients must follow a standard cholesterol-lowering diet. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. A dose of 5 ~ 40 mg of this drug once daily in the evening is recommended. Before starting treatment, adjust the dose as appropriate according to the baseline LDL cholesterol level, treatment goal, and patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if cholesterol levels fall below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of this drug at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this drug for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) For recommended doses in patients receiving this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), refer to the information below (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should receive 40 mg of this drug once daily in the evening. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this drug. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this drug is coadministered with verapamil, diltiazem, or dronedarone, the dose of this drug should not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this drug is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this drug should not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering drugs This drug is effective when used alone or in combination with bile acid sequestrants. When this drug is coadministered with fibrates (excluding gemfibrozil (see 2. Patients in whom the drug is contraindicated under Precautions for Use) and fenofibrate), the dose of this drug should not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this drug is not extensively excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg per day and monitor carefully.

Child dose

3. Administration to pediatric patients (10 ~ 17 years) with heterozygous familial hypercholesterolemia The recommended initial dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or more between dose adjustments.

Precautions

This medication may cause muscle problems; therefore, if you experience muscle pain or weakness while taking it, consult your doctor immediately. There may be cases where this medication cannot be taken, so please inform your doctor if you have any allergies, severe liver disease, are pregnant or nursing, or are taking other specific medications. Those with poor liver function or high alcohol intake, decreased kidney function, or hypothyroidism should use this medication with caution. Elderly patients and women are at an increased risk of muscle disorders, so special care is required when taking this medication. This medication can affect liver function, so regular liver function tests should be performed, and if symptoms of hepatitis or jaundice occur, it should be stopped immediately. There are many drug interactions, so you must inform your healthcare provider about taking this medication when starting any new medications, especially not to be taken with strong specific antifungal agents, antibiotics, and immunosuppressants. Avoid grapefruit juice or large amounts of grapefruit as it may increase the risk of side effects from this medication. Pregnant women or those who may become pregnant should avoid taking this medication, and if pregnancy is confirmed during use, it should be stopped immediately. Nursing mothers should also discontinue breastfeeding while taking this medication, and it should not be used in children and patients under 10 years old. Increased blood sugar levels during treatment may increase the risk of diabetes, so those requiring blood sugar management should check their blood sugar levels regularly. In case of overdose, seek medical attention immediately for appropriate treatment. This medication should be kept out of reach of children and stored in its original container.

Side effects

  • myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 87 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • cholecystitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • taste disturbance
  • ocular movement disorders
  • facial paralysis
  • tremors
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorder
  • anxiety
  • sleep disturbance
  • nightmares
  • depression
  • cognitive impairment
  • severe muscle weakness
  • ocular muscle weakness
  • hepatitis
  • liver dysfunction
  • jaundice
  • alopecia
  • pruritus
  • skin changes
  • lichen planus-like drug rash
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • increased fasting blood glucose levels
  • pancreatitis
  • liver failure
  • cholestatic jaundice
  • fatty liver changes
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • decreased appetite
  • vomiting
  • dry skin
  • hair changes
  • nail changes
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • erythema multiforme
  • thrombocytopenia
  • interstitial lung disease
  • limb sensory numbness
  • paresthesia
  • cold sensation
  • sensory disorders
  • muscle weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container at a temperature between 1°C and 30°C at room temperature. This will help to maintain the medication's effectiveness.

Appearance and packaging

Appearance

Brownish-yellow oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.